Search research articles
Contact Us
Filters
Showing results (71-80 of 457) with videos related to
Page
of 46
Sort By:
Brain Stimulation
|
December 14, 2020
Metabolic state and gustatory perception shapes dynamic interplay between cortical excitability and motor response
Christopher P Walker, Amber L McFerren, Davindra R Rammani, et al.
Advanced Drug Delivery Reviews
|
December 12, 2018
Advances in transdermal insulin delivery
Yuqi Zhang, Jicheng Yu, Anna R Kahkoska, et al.
American Journal of Epidemiology
|
September 8, 2024
High-dimensional Iterative Causal Forest (hdiCF) for Subgroup Identification Using Health Care Claims Data
Tiansheng Wang, Virginia Pate, Richard Wyss, et al.
Diabetes Care
|
September 26, 2015
Response to comment on Hempe et al. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care 2015;38:1067-1074
James M Hempe, Shuqian Liu, Leann Myers, et al.
Diabetes, Obesity & Metabolism
|
June 7, 2019
Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example
Vanita R Aroda, Trine Saugstrup, John B Buse, et al.
Journal of Dental Hygiene : JDH
|
May 16, 2012
Diabetes educators' knowledge, opinions and behaviors regarding periodontal disease and diabetes
Mary H Lopes, Janet H Southerland, John B Buse, et al.
Diabetes Care
|
November 30, 2012
Diabetes screening with hemoglobin A(1c) versus fasting plasma glucose in a multiethnic middle-school cohort
John B Buse, Francine R Kaufman, Barbara Linder, et al.
Journal of Clinical and Translational Science
|
June 30, 2021
Re-engineering The Clinical Research Enterprise in Response to COVID-19: The Clinical Translational Science Award (CTSA) experience and proposed playbook for future pandemics
Barry S Coller, John B Buse, Robert P Kimberly, et al.
Diabetes Care
|
December 18, 2020
Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes
Francesco Zaccardi, David E Kloecker, John B Buse, et al.
European Journal of Clinical Pharmacology
|
May 12, 2016
Effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors on colorectal cancer incidence and its precursors
Phyo T Htoo, John B Buse, Mugdha Gokhale, et al.
Page
of 46
Search research articles
Search
Showing results (71-80 of 457) with videos related to
Sort By:
Page
of 46
Brain Stimulation
|
December 14, 2020
Metabolic state and gustatory perception shapes dynamic interplay between cortical excitability and motor response
Christopher P Walker, Amber L McFerren, Davindra R Rammani, et al.
Advanced Drug Delivery Reviews
|
December 12, 2018
Advances in transdermal insulin delivery
Yuqi Zhang, Jicheng Yu, Anna R Kahkoska, et al.
American Journal of Epidemiology
|
September 8, 2024
High-dimensional Iterative Causal Forest (hdiCF) for Subgroup Identification Using Health Care Claims Data
Tiansheng Wang, Virginia Pate, Richard Wyss, et al.
Diabetes Care
|
September 26, 2015
Response to comment on Hempe et al. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care 2015;38:1067-1074
James M Hempe, Shuqian Liu, Leann Myers, et al.
Diabetes, Obesity & Metabolism
|
June 7, 2019
Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example
Vanita R Aroda, Trine Saugstrup, John B Buse, et al.
Journal of Dental Hygiene : JDH
|
May 16, 2012
Diabetes educators' knowledge, opinions and behaviors regarding periodontal disease and diabetes
Mary H Lopes, Janet H Southerland, John B Buse, et al.
Diabetes Care
|
November 30, 2012
Diabetes screening with hemoglobin A(1c) versus fasting plasma glucose in a multiethnic middle-school cohort
John B Buse, Francine R Kaufman, Barbara Linder, et al.
Journal of Clinical and Translational Science
|
June 30, 2021
Re-engineering The Clinical Research Enterprise in Response to COVID-19: The Clinical Translational Science Award (CTSA) experience and proposed playbook for future pandemics
Barry S Coller, John B Buse, Robert P Kimberly, et al.
Diabetes Care
|
December 18, 2020
Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes
Francesco Zaccardi, David E Kloecker, John B Buse, et al.
European Journal of Clinical Pharmacology
|
May 12, 2016
Effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors on colorectal cancer incidence and its precursors
Phyo T Htoo, John B Buse, Mugdha Gokhale, et al.
Page
of 46